About ONCOCROSS CO.,LTD.
Sector
Headquarters
Seoul
Founded
2015
Website
ISIN
KR7382150001
FIGI
BBG01QB23D57
Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. It provides a new approach to new drug development by sharing the analysis results using AI new drug development platform. The company was founded by Yi-Rang Kim on June 22, 2015 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 382150 is 8,360 KRW — it has decreased by −2.22% in the past 24 hours. Watch ONCOCROSS CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ONCOCROSS CO.,LTD. stocks are traded under the ticker 382150.
382150 stock has fallen by −33.91% compared to the previous week, the month change is a −33.91% fall, over the last year ONCOCROSS CO.,LTD. has showed a −33.91% decrease.
No, 382150 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 382150 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOCROSS CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.